Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF
Clinical trial NCT02846324 · COMPLETED
Trial details
- NCT number
- NCT02846324
- Sponsor
- Global Blood Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.